Formerly known an Altea Development Corporation, Altea Therapeutics developed products for delivery of macromolecular drugs (including peptides, proteins, and carbohydrates), as well as small drugs (e.g. pain medications). The firm used advanced delivery across the skin that improve the efficacy, safety and compliance of drugs and vaccines. Altea was dissolved in late 2011 after partners, including Eli Lilly and Hospira, pulled out of development deals.
